College of Engineering University of Wisconsin-Madison
Decorative header to link to Department of Biomedical Engineering

Graphic of the BME newsletter The Fountain
BME MONITOR: The Biomedical Engineering Department Newsletter


2007 Newsletter
Featured articles

Experiential learning: BME undergrad design competition stresses real-world challenges

Research may yield improved treatment of diseased lungs

Translational research: Medicine, hand-delivered

Translational research:
Ultrasound waves reflect tissue mechanics

Translational research: 'Balloon' effect:
Blocking aneurysms

Translational research: For ACL repair,
closing the 'gap'

Translational research: Fast, efficient MR imaging

Translational research: Seven new projects launched

Graduate student service award honors Corrine Bahr

Regular Features

Message from the chair

Faculty news:
David Beebe cited as pioneer of miniaturization

In memoriam:
Prof. Paul Bach-y-Rita

spacer Homepage for BME newsletter Button to obtain BACK ISSUES Button to CONTACT US Button to JOIN OUR MAILING LIST Button that connects to UW Foundation page for online giving  

Royal Society of Chemistry cites David Beebe as pioneer of miniaturization

David Beebe
David Beebe
(View larger image)

Decorative initial cap The journal Lab on a Chip, the European-based Royal Society of Chemistry, and Corning Inc. have awarded the first-ever Pioneers of Miniaturization prize to Professor David Beebe.

An award for young- to mid-career scientists, the prize recognizes Beebe’s outstanding contributions to the understanding and development of miniaturized systems. Beebe, who holds more than 20 patents or patents pending for microfluidic devices and related applications, received the award in early November at the μTAS 2006 (the 10th international conference on miniaturized systems for chemistry and life sciences) in Tokyo.

Beebe develops and applies microtechnology to solve problems in biology and medicine. Among his recent projects are a patch for delivering large-molecule drugs — for example, a time-release overnight dose of insulin for juvenile diabetes sufferers — and a family of microfluidic-based tools for studying basic cell biology questions related to cancer, developmental biology and stem cells.

In addition to his patents in microfluidics and miniature systems, Beebe also has co-founded three biotechnology companies — Vitae LLC, Ratio Inc., and Salus Discovery LLC — that are commercializing his technologies.

Read more about Beebe and his work at and at


For help with this webpage:

Copyright 2007 The Board of Regents of the University of Wisconsin System

Date last modified: Monday,30-July-2007 15:43:00 CDT
Date created: 30-July-2007



Graphic of the Biomedical Engineering newsletter